Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MNOV [NASD]
MediciNova Inc.
Index- P/E- EPS (ttm)-0.52 Insider Own2.50% Shs Outstand24.09M Perf Week-3.98%
Market Cap46.49M Forward P/E- EPS next Y- Insider Trans-10.41% Shs Float20.37M Perf Month-10.65%
Income-9.90M PEG- EPS next Q- Inst Own8.40% Short Float1.58% Perf Quarter-22.80%
Sales6.00M P/S7.75 EPS this Y45.00% Inst Trans0.10% Short Ratio2.31 Perf Half Y-28.78%
Book/sh0.96 P/B2.01 EPS next Y- ROA-42.50% Target Price6.00 Perf Year-24.02%
Cash/sh0.44 P/C4.35 EPS next 5Y20.00% ROE-53.30% 52W Range1.66 - 5.25 Perf YTD-9.81%
Dividend- P/FCF- EPS past 5Y30.80% ROI-73.20% 52W High-63.24% Beta1.22
Dividend %- Quick Ratio10.00 Sales past 5Y- Gross Margin- 52W Low16.27% ATR0.13
Employees11 Current Ratio10.00 Sales Q/Q17549.10% Oper. Margin- RSI (14)43.56 Volatility8.54% 6.98%
OptionableNo Debt/Eq0.00 EPS Q/Q28.60% Profit Margin- Rel Volume0.30 Prev Close1.86
ShortableYes LT Debt/Eq0.00 EarningsNov 07 Payout- Avg Volume139.34K Price1.93
Recom1.00 SMA20-5.14% SMA50-9.56% SMA200-17.64% Volume41,406 Change3.76%
04-Jan-13Reiterated Ladenburg Thalmann Buy $10.50 → $6
24-May-12Downgrade MLV & Co Buy → Hold
18-Oct-11Reiterated MLV Capital Buy $13 → $6
22-Jun-11Initiated Global Hunter Securities Buy $4
12-May-10Initiated Wedbush Outperform $13
12-Nov-08Reiterated Ladenburg Thalmann Buy $22 → $6
15-May-08Initiated Rodman & Renshaw Mkt Outperform $9
09-Jul-07Initiated Punk, Ziegel & Co Buy $22
09-Apr-14 06:01AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic EDGAR Online
08-Apr-14 07:00PM  MediciNova Appoints Yoshio Ishizaka to its Board of Directors GlobeNewswire +9.04%
07:00PM  MediciNova Announces Management Appointment GlobeNewswire
11:00AM  Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides Accesswire
03-Apr-14 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
28-Mar-14 06:07AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
27-Mar-14 05:04PM  MEDICINOVA INC Files SEC form 10-K, Annual Report EDGAR Online
10-Mar-14 09:00AM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
25-Feb-14 04:47PM  MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected at Seeking Alpha
04:47PM  MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected
17-Jan-14 03:52PM  Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week at TheStreet
03:52PM  Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week
14-Jan-14 08:00AM  MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S. GlobeNewswire +32.09%
08:00AM  MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S.
13-Jan-14 05:16PM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
05:16PM  MEDICINOVA INC Files SEC form 8-K, Other Events
30-Dec-13 06:10AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:10AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers
13-Dec-13 06:07AM  MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session Zacks -10.98%
06:07AM  MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session
15-Nov-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
01:04PM  MEDICINOVA INC Financials
13-Nov-13 06:02AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic EDGAR Online
06:02AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
11-Nov-13 06:00PM  MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome GlobeNewswire
06:00PM  MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome
08-Nov-13 06:19AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online -6.11%
06:19AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure
07-Nov-13 06:30PM  MediciNova Reports Third Quarter 2013 Results GlobeNewswire
06:30PM  MediciNova Reports Third Quarter 2013 Results
05:17PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05:17PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report
18-Oct-13 03:19PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
03:19PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
16-Oct-13 05:00PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A EDGAR Online +5.04%
05:00PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A
05:00PM  MediciNova Appoints Yutaka Kobayashi to Its Board of Directors GlobeNewswire
04:30PM  InPlay: MediciNova appoints Geoffrey O'Brien as Vice President Briefing.com
04:30PM  MediciNova Appoints Geoffrey O'Brien as Vice President GlobeNewswire
06-Oct-13 07:00PM  MediciNova Receives Notice of Allowance for New Patent Covering MN-029 (denibulin) di-hydrochloride GlobeNewswire
26-Sep-13 04:17PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
25-Aug-13 07:00PM  National Institute on Alcohol Abuse and Alcoholism Funds New UCLA Clinical Trial of MediciNova's MN-166 in Treating Alcoholism GlobeNewswire
20-Aug-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
09-Aug-13 09:01AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-Aug-13 05:30PM  MediciNova Reports Second Quarter 2013 Results GlobeNewswire
05:11PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
30-Jul-13 09:02AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
18-Jul-13 07:00PM  MediciNova Announces Initiation of a Cooperative Phase 2b Trial of MN-166 in Progressive Multiple Sclerosis GlobeNewswire
17-Jul-13 09:03AM  MEDICINOVA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
20-Jun-13 06:48PM  Nasdaq stocks posting largest volume increases AP -11.87%
19-Jun-13 06:05PM  Nasdaq stocks posting largest volume increases AP +31.13%
05:15PM  MediciNova Presents MN-166 Data Zacks
18-Jun-13 06:04PM  InPlay: MediciNova: UCLA presents data on MediciNova's MN-166 in methamphetamine addicition Briefing.com
06:00PM  UCLA Presents Data on MediciNova's MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence GlobeNewswire
17-Jun-13 07:32AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu EDGAR Online
07-Jun-13 10:21AM  MEDICINOVA INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr EDGAR Online
14-May-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials -6.10%
13-May-13 01:34PM  Monday Sector Leaders: Biotechnology, Drugs at Forbes +16.48%
09-May-13 11:13PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities EDGAR Online -26.78%
02:01AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-May-13 05:30PM  MediciNova Reports First Quarter 2013 Results GlobeNewswire +10.50%
10:10AM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
18-Apr-13 06:35AM  MedicNova enters into 6M equity distribution agreement with Macquarie at theflyonthewall.com +6.72%
17-Apr-13 11:19PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
09:08AM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
03-Apr-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
29-Mar-13 02:02AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
28-Mar-13 05:30PM  MediciNova Reports Fourth Quarter and Full Year 2012 Results GlobeNewswire
10:16AM  MEDICINOVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
10:08AM  MEDICINOVA INC Files SEC form 10-K, Annual Report EDGAR Online
21-Mar-13 01:23AM  InPlay: MediciNova presents data from MN-166 opioid withdrawal and analgesia data Briefing.com
20-Mar-13 07:00PM  MediciNova Announces MN-166 (ibudilast) Opioid Withdrawal and Analgesia Data Presentation at the American Academy of Neurology Annual Meeting GlobeNewswire +5.71%
03-Mar-13 08:32AM  5 of Last Week's Biggest Winners at Motley Fool
01-Mar-13 05:02PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -12.35%
28-Feb-13 03:24PM  Thursdays movers: Herbalife gets more Icahn lift at MarketWatch +7.59%
01:45PM  Thursdays movers: Sears covered in red ink at MarketWatch
11:18AM  Thursdays movers: J.C. Penney is S&P 500 laggard at MarketWatch
10:27AM  Thursdays movers: Groupon sinks on surprise loss at MarketWatch
09:09AM  Thursdays biggest gaining and declining stocks at MarketWatch
27-Feb-13 06:02PM  Nasdaq stocks posting largest volume increases AP +6.04%
01:49PM  Secretive Dilution And A Possible Equity Financing From MediciNova at Seeking Alpha
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwired
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire
26-Feb-13 06:15PM  Nasdaq stocks posting largest volume increases AP +39.25%
05:54PM  4 Healthcare Stock Stories to Heal the Tuesday Blues at Wall St. Cheat Sheet
25-Feb-13 06:01PM  InPlay: MediciNova: FDA grants Fast Track designation for MediciNova's MN-166 (ibudilast) for the treatment of methamphetamine dependence Briefing.com +5.42%
06:00PM  FDA Grants Fast Track Designation for MediciNova's MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence GlobeNewswire
03-Jan-13 06:00PM  MediciNova Provides Development Update GlobeNewswire
09-Dec-12 06:30PM  MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma GlobeNewswire
20-Nov-12 06:01PM  InPlay: MediciNova announces initiation of a clinical trial of MN-166 in opioid abusers Briefing.com
06:00PM  MediciNova Announces Initiation of a Clinical Trial of MN-166 in Opioid Abusers With Columbia University and the New York State Psychiatric Institute GlobeNewswire
18-Nov-12 06:00PM  MediciNova Extends MN-166 Patent Position in Europe GlobeNewswire
16-Nov-12 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials -10.11%
14-Nov-12 06:00PM  MediciNova to Present at the Fourth World Congress of Emergency Medicine GlobeNewswire -5.10%
12-Nov-12 06:05PM  MedicNova announces publication of positive phase 2 clinical results theflyonthewall.com
06:00PM  MediciNova Announces Publication of MN-221 Clinical Results in Journal of Asthma GlobeNewswire
09-Nov-12 09:02AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-Nov-12 06:00PM  MediciNova Reports Third Quarter 2012 Results and Update on MN-221 Development GlobeNewswire
05:15PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
07-Nov-12 06:00PM  MediciNova to Present at the Lazard Capital Markets Healthcare Conference GlobeNewswire
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a 2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.